• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Genetron Holdings Limited (GTH) Stock Price, News & Analysis

Genetron Holdings Limited (GTH) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$4.02
Day's range
$4.05
50-day range
$3.74
Day's range
$4.05
  • Country: CN
  • ISIN: US37186H2094
52 wk range
$2.08
Day's range
$4.05
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -9.95
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (GTH)
  • Company Genetron Holdings Limited
  • Price $4.03
  • Changes Percentage (0.12%)
  • Change $0.01
  • Day Low $4.02
  • Day High $4.05
  • Year High $4.05

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 01/17/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Buy
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$3.62
  • Trailing P/E Ratio -1.1118784530387
  • Forward P/E Ratio -1.1118784530387
  • P/E Growth -1.1118784530387
  • Net Income $-883,889,000

Income Statement

Quarterly

Annual

Latest News of GTH

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Genetron Holdings Limited Frequently Asked Questions

  • What is the Genetron Holdings Limited stock price today?

    Today's price of Genetron Holdings Limited is $4.03 — it has increased by +0.12% in the past 24 hours. Watch Genetron Holdings Limited stock price performance more closely on the chart.

  • Does Genetron Holdings Limited release reports?

    Yes, you can track Genetron Holdings Limited's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Genetron Holdings Limited stock forecast?

    Watch the Genetron Holdings Limited chart and read a more detailed Genetron Holdings Limited stock forecast to see what analysts suggest you do with its shares.

  • What is Genetron Holdings Limited stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Genetron Holdings Limited stock ticker.

  • How to buy Genetron Holdings Limited stocks?

    Like other stocks, GTH shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Genetron Holdings Limited's EBITDA?

    Genetron Holdings Limited measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Genetron Holdings Limited’s financial statements.

  • What is the Genetron Holdings Limited's net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -1.3583538495, which equates to approximately -135.84%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Genetron Holdings Limited stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Genetron Holdings Limited's financials relevant news, and technical analysis. Genetron Holdings Limited's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Genetron Holdings Limited stock currently indicates a “sell” signal. For more insights, review Genetron Holdings Limited’s technical analysis.

  • A revenue figure for Genetron Holdings Limited for its last quarter?

    Genetron Holdings Limited published it's last quarterly revenues at $201.32 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.